An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Mandal, Soma ^a   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROTEASOME; ESTRADIOL;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME 19Q; CONTROLLED STUDY; DOWN REGULATION; ELECTRON TRANSPORT; ENERGY YIELD; GENE CLUSTER; GENE LOCATION; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PROGNOSIS; PROTEIN DEGRADATION; RIBOSOME; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLIC NETWORKS AND PATHWAYS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 37449032683     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-181     Document Type: Article

References (55)

1. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC: Production and actions of estrogens. N Engl J Med 2002, 346:340-352. 10.1056/ NEJMra000471 11821512
2. De CA, Favoni RE: Oestrogen/growth factor cross-talk in breast carcinoma: A specific target for novel antioestrogens. Trends Pharmacol Sci 1997, 18:245-251. 9253856
3. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM: William L. McGuire Memorial Lecture. Antiestrogens: Mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 1997, 44:23-38. 10.1023/A:1005835428423 9164675
4. Seth P, Krop I, Porter D, Polyak K: Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 2002, 21:836-843. 10.1038/sj.onc.1205113 11850811
5. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K: Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003, 1:362-375. 12651909
6. Abba MC, Hu Y, Sun H, Drake JA, Gaddis S, Baggerly K, Sahin A, Aldaz CM: Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 2005, 6:37. 555753 15762987 10.1186/1471-2164-6-37
7. Jonsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, Osoegawa K, de JP, Oredsson S, Ringner M, Hoglund M, Borg A: High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007, 46:543-558. 10.1002/gcc.20438 17334996
8. 2007 http://cgap.nci.nih.gov
9. 2007 http://smd.stanford.edu
10. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM: Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 2000, 60:5977-5983. 11085516
11. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32. 10.1016/j.ccr.2004.06.010 15261139
12. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995, 270:484-487. 10.1126/science.270.5235.484 7570003
13. RAmualdi C, Bortoluzzi S, D'Alessi F, Danieli GA: IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments. Physiol Genomics 2003, 12:159-162. 12429865
14. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868. 24541 9843981 10.1073/pnas.95.25.14863
15. Dennis G Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:3. 10.1186/gb-2003-4-5-p3
16. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002, 31:19-20. 10.1038/ng0502-19 11984561
17. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR: MAUPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003, 4:R7. 151291 12540299 10.1186/gb-2003-4-1-r7
18. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550. 1239896 16199517 10.1073/pnas.0506580102
19. Phillips KK, Welch DR, Miele ME, Lee JH, Wei LL, Weissman BE: Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 1996, 56:1222-1227. 8640802
20. Zhu Y, Wang A, Liu MC, Zwart A, Lee RY, Gallagher A, Wang Y, Miller WR, Dixon JM, Clarke R: Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol 2006, 29:1581-1589. 17089000
21. bd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO: Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004, 203:661-671. 10.1002/path.1559 15141381
22. Rubio SA, Martinez SE, Corona JS, Ruiz AP, Rincon AE, Lagunas IA, Camacho JG, Moguel MC: EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer. Breast Cancer Res Treat 2006, 96:159-161. 10.1007/s10549-005-9072-0 16317582
23. Mandal S, Curtis L, Pind M, Murphy LC, Watson PH: S100A7 (psoriasin) influences immune response genes in human breast cancer. Exp Cell Res 2007, 313:3016-3025. 10.1016/j.yexcr.2007.03.020 17560571
24. Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi-Boyer V, Esterni B, Geneix J, Finetti P, Zemmour C, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Chaffanet M: Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 2006, 6:245. 1626089 17040570 10.1186/1471-2407-6-245
25. Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM: Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene 2006, 25:5517-5526. 10.1038/ sj.onc.1209563 16619035
26. Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ: At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994, 9:101-107. 10.1002/ gcc.2870090205 7513539
27. Wennmalm K, Calza S, Ploner A, Hall P, Bjohle J, Klaar S, Smeds J, Pawitan Y, Bergh J: Gene expression in 16q is associated with survival and differs between Sorlie breast cancer subtypes. Genes Chromosomes Cancer 2007, 46:87-97. 10.1002/gcc.20392 17044045
28. Chen J, Lindblom A: Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p. Clin Genet 2000, 57:394-397. 10.1034/j.1399-0004.2000.570511.x 10852375
29. Olayioye MA, Hoffmann P, Pomorski T, Armes J, Simpson RJ, Kemp BE, Lindeman GJ, Visvader JE: The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Res 2004, 64:3538-3544. 10.1158/ 0008-5472.CAN-03-3731 15150109
30. Liu PC, Koeller DM, Kaler SG: Genomic organization of ATOX1, a human copper chaperone. BMC Genet 2003, 4:4. 150598 12594858 10.1186/ 1471-2156-4-4
31. Cuesta R, Laroia G, Schneider RJ: Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev 2000, 14:1460-1470. 316692 10859165
32. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM: Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005, 337:224-231. 10.1016/j.bbrc.2005.09.040 16176802
33. Krone CA, Ely JT: Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 2005, 4:25-31. 10.1177/1534735404274167 15695475
34. Chevrollier A, Loiseau D, Chabi B, Renier G, Douay O, Malthiery Y, Stepien G: ANT2 isoform required for cancer cell glycolysis. J Bioenerg Biomembr 2005, 37:307-316. 10.1007/s10863-005-8642-5 16341775
35. Henry JL, Coggin DL, King CR: High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 1993, 53:1403-1408. 8095182
36. Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK: Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 2002, 23:967-975. 10.1093/carcin/23.6.967 12082018
37. Ren S, Smith MJ, Louro ID, Kie-Bell P, Bani MR, Wagner M, Zochodne B, Redden DT, Grizzle WE, Wang N, Smith DI, Herbst RA, Bardenheuer W, Opalka B, Schutte J, Trent JM, Ben-David Y, Ruppert JM: The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma. Oncogene 2000, 19:1419-1427. 10.1038/sj.onc.1203462 10723133
38. Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996, 65:801-847. 10.1146/ annurev.bi.65.070196.004101 8811196
39. Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, Watson PH: Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res 2004, 10:8720-8727. 10.1158/1078-0432.CCR-04-1235 15623657
40. Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, Okada F, Sato S, Shimbara N, Ichihara A: Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res 1991, 51:6677-6685. 1660345
41. Onda M, Emi M, Yoshida A, Miyamoto S, Akaishi J, Asaka S, Mizutani K, Shimizu K, Nagahama M, Ito K, Tanaka T, Tsunoda T: Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. Endocr Relat Cancer 2004, 11:843-854. 10.1677/ erc.1.00818 15613457
42. Saeki Y, Sone T, Yokosawa H: Identification of ubiquitin-like protein-binding subunits of the 26S proteasome. Biochem Biophys Res Commun 2002, 296:813-819. 10.1016/S0006-291X(02)02002-8 12200120
43. Nishida H, Suzuki T, Ookawa H, Tomaru Y, Hayashizaki Y: Comparative analysis of expression of histone H2a genes in mouse. BMC Genomics 2005, 6:108. 1198228 16098230 10.1186/1471-2164-6-108
44. Faast R, Thonglairoam V, Schulz TC, Beall J, Wells JR, Taylor H, Matthaei K, Rathjen PD, Tremethick DJ, Lyons I: Histone variant H2A.Z is required for early mammalian development. Curr Biol 2001, 11:1183-1187. 10.1016/S0960-9822(01)00329-3 11516949
45. Dunn KL, Espino PS, Drobic B, He S, Davie JR: The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 2005, 83:1-14. 10.1139/o04-121 15746962
46. Surmacz E: Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 2000, 5:95-105. 10.1023/A:1009523501499 10791772
47. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494. 10.1126/ science.270.5241.1491 7491495
48. Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P, Pignatelli M: Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology 2002, 40:536-546. 10.1046/ j.1365-2559.2002.01392.x 12047765
49. Dabbs DJ, Bhargava R, Chivukula M: Lobular versus ductal breast neoplasms: The diagnostic utility of p120 catenin. Am J Surg Pathol 2007, 31:427-437. 10.1097/01.pas.0000213386.63160.3f 17325485
50. Kulka J, Tokes AM: Claudin expression in breast tumors. Hum Pathol 2005, 36:859. 10.1016/j.humpath.2005.04.005 16084960
51. Colegio OR, Van IC, Rahner C, Anderson JM: Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 2003, 284:C1346-C1354. 12700140
52. Zhang H, Stephens LC, Kumar R: Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer2. Clin Cancer Res 2006, 12:1479-1486. 10.1158/1078-0432.CCR-05-1519 16533771
53. Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY: Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: A multigenic study on cancer susceptibility. J Biomed Sci 2006, 13:419-432. 10.1007/s11373-006-9069-7 16502042
54. Basolo F, Conaldi PG, Fiore L, Calvo S, Toniolo A: Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: Defective IL6 expression in mammary carcinoma. Int J Cancer 1993, 55:926-930. 10.1002/ijc.2910550609 8253529
55. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874. 58566 11553815 10.1073/pnas.191367098